The Ben Franklin Technology Development Authority has approved $3.15 million to be used for the University Research Commercialization Grant Program to support nanotechnology research and development activities.
mPhase Technologies, Inc. has developed a technology that exploits the phenomenon of electrowetting or the ability to electronically manipulate the way liquids behave when in contact with a solid or porous surface.
Microfluidics expert, Dolomite, is delighted to announce its collaboration with Clearbridge BioMedics in the development of a novel instrument capable of detecting and isolating Circulating Tumour Cells from small quantities of whole, unprocessed blood.
Japanese Society of Microscopy has announced that Park Systems Japan will be the sponsor for its upcoming AFM Bio-Imaging Forum. Set to take place at WINC AICHI in Nagoya on Tuesday, December 27th, 2011, the forum will invite leading Japanese scientists and researchers who apply state of the art AFM techniques to study biophysics, biochemistry, and cell biology.
Park Systems has introduced the NX10, the world's most accurate AFM, as the flagship AFM of its new product line. Now available worldwide, the NX10 brings unparalleled imaging accuracy, scan speeds, and tip life to the next generation of researchers, all at an affordable price.
Nanda has developed a high-throughput, high-sensitivity defect inspection technology for semiconductor manufacturing. With this acquisition, Nanometrics adds a highly differentiated and leading-edge macro defect inspection technology to its portfolio of industry-leading metrology solutions.
The new software integrates Chinese GB/T standard references for surface texture parameter families thereby extending the MountainsMap "right parameters wherever you are" feature to include eight national references in addition to ISO references.
Dolomite, a world leader in the design and manufacture of microfluidic devices, has launched a new white paper addressing the challenges faced by engineers and scientists when working with microfluidic connections.
Many hearing aid users have experienced the frustration of having their hearing aids malfunction and become damaged due to moisture and perspiration. One Tulsa company is employing nanotechnology to solve the problem.
Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG.